{
  "pmcid": "12409644",
  "sha256": "a76ac2b71a5883f8ba18cd603d7ab7fccca72483483e786299c2ddb07adcc221",
  "timestamp_utc": "2025-11-09T15:40:08.513407+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.12374540553786,
    "reading_ease": 31.007896961529042,
    "word_count": 371
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Importance: Acute normovolemic hemodilution (ANH) is a well-known blood conservation technique, yet its adoption in the US remains low (<20%), and cardiac surgery remains the largest consumer of blood components."
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Design, Setting, and Participants: A retrospective propensity–score matched cohort study using data from the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database (version 4.20.2)."
      },
      "Participants": {
        "score": 2,
        "evidence": "The study included adult patients (≥18 years) undergoing coronary artery bypass grafting (CABG) and/or valve surgery with CPB (July 2020 to September 2023)."
      },
      "Intervention": {
        "score": 1,
        "evidence": "Exposure: The primary exposure was ANH, defined as any recorded use/volume in the STS database."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To evaluate ANH use in perioperative transfusion and blood component use in patients undergoing surgery with cardiopulmonary bypass (CPB)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Main Outcome and Measures: The primary outcome was intraoperative or postoperative transfusion of any blood component."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Results: Among 16 795 patients (mean [SD] age, 65.3 [10.5] years; 12 114 male [72.1%]), ANH was reported in 2463 cases (14.7%)."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "After propensity score matching (n = 2282 pairs), transfusion rates were significantly lower in the ANH group (31.2% vs 36.4%; P < .001)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "ANH was associated with 27% lower odds of any transfusion (odds ratio, 0.73; 95% CI, 0.60-0.89)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}